QIAGEN und CENTOGENE kündigen Zusammenarbeit im Bereich Bioinformatik für Erbkrankheiten an
QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) und die CENTOGENE AG gaben heute eine Vereinbarung über die gemeins…
QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) und die CENTOGENE AG gaben heute eine Vereinbarung über die gemeins…
CENTOGENE announces today a new sequencing facility for rare hereditary disorders, which will use Illumina's HiSeq X® se…
Centogene AG (CENTOGENE) and Interactive Biosoftware (IBS) announce to start their collaboration on the integration of C…
With the upcoming release of CentoMD® 3.1 end of September 2016, CENTOGENE will report genetic information and clinical…
CENTOGENE AG (“CENTOGENE”) announces the launch of the completely updated CentoMD® 3.0 CentoMD®, the world’s leading pr…
CENTOGENE AG ("CENTOGENE") announces the launch of the world's largest genetic mutation database for rare diseases, Cent…